The association of aloe and Î²-carotene supplementation improves oxidative stress and Inflammatory state in pregnant buffalo cows by Lombardi, P. et al.
Buffalo Bulletin (July-September 2017) Vol.36 No.3
497
ABSTRACT
The complex polysaccharides of Aloe have 
been reported to improve immunity and oxidative 
status either in vitro or in vivo studies. Further, 
β-carotene has been shown to influence immune 
function and health in the cow. In this study, the 
effects of VigoorsanTM, a commercial supplement 
containing Aloe arborescence and β-carotene, on 
biochemical profile and oxidative/inflammatory 
status, were evaluatedin pregnant buffalo cows. 
VigoorsanTM was supplied (50 g/day/head) to 
pluriparae buffalo cows for 30 days before delivery. 
A significant increase of BAP and OXY and a 
decrease of d-ROMs (P<0.01) were detected in 
blood from cows supplemented with VigoorsanTM. 
Further, a decrease of TNF-α, IL1-βand MCP-1 
and an increase of IL-10 were showed (P<0.01). 
Blood chemistry profiles showed no adverse 
effects on health status. Results showed that 
VigoorsanTM supplementation improves oxidative 
and inflammatory status with no negative effects 
on metabolism in water buffalo cow. 
Keywords: buffaloes, Bubalus bubalis, Aloe 
arborescence, β-carotene, oxidative status, 
inflammation
INTRODUCTION
Transition is a highly demanding 
period that can be affected by many factors 
that could compromise the health, productivity 
and reproductive performance of dairy cows. 
Nutritional strategies can be used to prevent 
metabolic diseases in the early days post-calving, 
and to improve milk production. A wide variety of 
additional feed additives exist that may also have 
potential for use over a few weeks pre-partum. The 
genus Aloe plant, whose four species namely, Aloe 
barbadensis Miller, Aloe ferox, Aloe arborescens 
and Aloe perryi baker have been traditionally 
applied for the medicinal practice over thousands 
of years in many cultures of the world. Recent 
studies suggested it could play an interesting role 
in improving health status and, as a consequence, 
performance in ruminants.
Several studies showed a lot of beneficial 
properties of Aloe spp. (Boudreau and Beland, 
2006). Aloe gel possesses wound healing (Heggers, 
1993), anti-inflammatory (Vazquez, 1996), to treat 
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oncology pain (Looney, 2010), antiviral (Saoo, 
1996), spermicidal (Fahim, 1996) and gastro-
protective (Danhof, 1991), cicatrising (Davis et al., 
1994) properties. Immune-stimulating (Infascelli 
et al., 2010), anti-proliferative (Di Luccia et al., 
2013) and cholesterol-lowering (Tizard et al., 
1989) activities have also been shown.
Several researchers have demonstrated 
that the mucilaginous polysaccharides contained in 
the clear pulp of Aloe leaf are the major ingredient 
responsible for the healing. Many of Aloe effects 
may derive from its activity on intestinal function, 
thus influencing absorption and availability of 
key substances (Calabrò et al., 2013). Indeed, 
the complex polysaccharides of Aloe have been 
reported as potent B cell stimulators either in vitro 
(Leung et al., 2004) and in vivo (Liu et al., 2006) 
studies. 
Moreover, several studies have shown the 
importance of β-carotene, the natural precursor for 
vitamin A (retinol) in ruminants, on reproduction, 
immune function and health in the cow and calf 
(Michal et al., 1994; Kume and Toharmat, 2001). 
Dietary β-carotene has been showed to elevate 
peri-partum concentrations of blood β-carotene, 
thus enhancing host defence mechanisms by 
potentiating lymphocyte and phagocyte functions, 
and decreasing the incidence of certain reproductive 
disorders (Michal et al., 1994). The majority of raw 
materials used to feed dairy cows are very poor 
sources of β-carotene and plasma concentrations of 
β-carotene have been shown to decrease in dairy 
cows during the pre-partum period, therefore, a 
supplementation of this precursor is recommended 
(Kawashima et al., 2009). In a recent study, a dietary 
supplement of β-carotene given in late-gestation 
was able to increase β-carotene concentrations in 
cows blood and in colostrum but was unable to 
increase colostral IgG (Kaewlamun et al., 2011).
This research aimed to explore the influence 
of supplying the diet of pregnant buffalo cows with 
VigoorsanTM, a feeding supplies containing Aloe 
arborescens and β-carotene, on the biochemical 
profile, oxidative stress and inflammatory state. 
MATERIALS AND METHODS
Twenty Italian Mediterranean pluriparae 
buffalo cows were divided into two groups 
(homogeneous for parity, BCS and milk yield in 
the previous lactations).
Health status of animals was monitored 
daily based on clinical signs of disease by trained 
individuals and on a weekly basis by a veterinary 
practitioner. Starting at 60 days prior to the expected 
date of calving (evaluated by ultrasonography) 
cows were monitored daily and fed a diet (12.5 kg 
dry matter/head/die: crude proteins 12% DM; 6.0 
MJ/kg DM) constituted by oat straw, corn silage 
and a commercial concentrate. For 30 days before 
calving, group B received a supplementation of 
50g/day/head of VigoorsanTM, while group A was 
used as control.
Before and after 30 days of VigorsaanTM 
supplementation, blood samples were obtained 
from the coccygeal vein at 07:00 am before 
feeding. All blood samples were collected into 10 
ml vacutainer tubes (Becton Dickinson, Franklin 
Lakes, NJ, USA) and allowed to clot and kept at 
4°C until separation of serum. Clotted blood was 
centrifuged at 1600 x g at 4°C for 20 minutes. 
The separated serum samples were stored at 
-80°C until analysis to avoid loss of bioactivity 
and contamination and were thawed on ice for 
approximately 2 h before use.
Blood chemistry analyses were performed 
by an automatic biochemical analyser AMS 
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Autolab (Analyzer Medical System, Rome, Italy) 
using reagents from Spinreact (Girona, Spain) to 
determine: blood urea nitrogen (BUN), creatinine 
(CREA), glucose (GLU), aspartate amino transferase 
(AST), cholesterol (CHO) and triglycerides (TRI); 
reagents from Catachem (Bridgeport-Connecticut-
USA) to determine β-hydroxybutyric acid 
(B-HBA), reagents from Randox (Ireland) for non 
esterified fatty acids (NEFA), and from Diacron 
International s.r.l. (Grosseto, Italy) to assess 
reactive oxygen metabolites (d-ROMs), biological 
antioxidant potential (BAP), OXY-adsorbent 
(OXY) tests. Serum levels of interleukin-1β (IL-
1β), interleukin-10 (IL-10), tumour necrosis factor 
(TNF-α), and monocyte chemo-attractant protein-1 
(MCP-1) were measured using commercially 
available ELISA kits (Genorise Scientific, INC).
One-way ANOVA was used to detect 
statistical differences between groups using the 
statistical model (GLM procedure, SAS, 2000):
yij = μ + Dieti + εij
Where: y is the experimental data, μ the 
general mean, Diet (i = A, B), ε the error term. 
RESULTS AND DISCUSSION
Blood chemistry parameters (Table 1) 
were in the normal range for the physiologic 
state of animals and no significant difference was 
detected between groups, thus showing animals 
were in good health and no adverse effect occurred 
after VigoorsanTM supplementation.
Results concerning the oxidative status 
after 30 days of treatmentstrongly suggest the 
beneficial effects of VigoorsanTM in terms of cellular 
health (Table 2). The d-Roms were lower in group 
B showing a general decrease of ROS production. 
A high level of ROS due to an increased 
production of oxidant species and/or a decreased 
efficacy of antioxidant system can lead to oxidative 
stress, an emerging health risk factor involved in 
many diseases, including inflammatory, infectious 
and degenerative disorders, both in humans and in 
animals (Halliwell and Cross, 1994; Bildik et al., 
2004; Kiral et al., 2005; Roncoroni et al., 2014; 
Vajdovich et al., 2005). The d-ROMs test provides 
a measure of the whole oxidant capacity of plasma 
and its decrease is considered a measure of cellular 
health. The lower d-ROMs level in the VigoorsanTM 
group is probably due to an improvement of the 
biological antioxidant potential, as confirmed 
by the increase of BAP and OXY levels. Such a 
biological antioxidant potential is attributed to the 
major component of plasma barrier to oxidation 
(vitamin C, vitamin E, uric acid, bilirubin and so 
on) (Benzie and Strain, 1996; Dohi et al., 2005; 
Hetyey et al., 2007).
Table 1. Blood chemistry parameters in control (Group A) and supplemented with 50 mg/kg/die of VigoorsanTM 
for 30 days (Group B) cows.
Group GOT TRI GLU CHOL NEFA BHBA BUN CREA
U/L mg/dl mg/dl mg/dl μmol/l mg/dl mg/dl mg/dl
A 127 25.6 75.5 34.5 69.9 5.1 15.8 0.9
B 119 37.7 71.8 34.3 59.9 5.8 17.7 0.8
MSE 6.1 3.2 5.4 2.4 9.1 0.4 1-0 0.04
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The beneficial effects of VigoorsanTM 
are also confirmed by the decrease of IL-1β, 
TNF-α and MCP-1 and by the increase of IL-10. 
Interleukin-1β is an important mediator of the 
inflammatory response, and is involved in a variety 
of cellular activities, including cell proliferation, 
differentiation, and apoptosis (Auron et al., 1984). 
TNF-α is produced primarily by macrophages, 
but also by a broad variety of cell types including 
lymphoid cells, mast cells, endothelial cells, 
cardiac myocytes, adipose tissue, fibroblasts, 
and neuronal tissue (Aggarwal et al., 2003). 
Cellular response to TNF-α results in activation 
of pathways that favour both cell survival and 
apoptosis depending on the cell type and biological 
context. TNF-α plays a key regulatory role in 
inflammation and host defence against bacterial 
infection and causes many of the clinical problems 
associated with autoimmune disorders (Lin et 
al., 2007). Monocyte chemoattractant protein-1 
(MCP-1) is a representative of the CC chemokine 
group, and its main known function is related to 
guiding monocytes to leave the circulation and 
become tissue macrophages, the first step in the 
initiation of inflammation. Several studies show 
that alterations in plasma MCP-1 concentrations in 
metabolic disease states, the presence of circulating 
chemokine reservoirs and recent novel mechanisms 
of action are associated with metabolic disturbances 
and suggest that MCP-1 might have systemic role 
in metabolic regulation (Rull et al., 2010).
Interestingly, TNF-α, and IL-1β 
concentrations were significantly decreased in 
VigoorsanTM group compared to control, indicating 
a possible anti-inflammatory role of VigoorsanTM. 
This hypothesis has been further supported by 
results related to IL-10. This anti-inflammatory 
cytochine was found to increase by nearly two-
fold in the VigoorsanTM group compared to control. 
IL-10 is an anti-inflammatory cytokine that is 
produced by T cells, NK cells, mast-cells and 
macrophages (Pestka et al., 2004; Akuffo et al., 
1999; Grimbaldeston et al., 2007). It is capable of 
inhibiting synthesis of pro-inflammatory cytokines 
like TNF-α. In addition, IL-10 is an important 
negative regulator of the immune response, which 
allows for maintenance of pregnancy (Pestka et al., 
2004).
Our data provide evidence that dietary 
supplementation with VigoorsanTM decreases 
inflammation and oxidative stress. Such beneficial 
effects could have important consequences on 
animal performance, so far, it could be involved 
in the improvement of immunity, as suggested by 
Infascelli et al. (2010). In any event, the possible 
benefits in terms of animal welfare and animal 
Table 2. Oxidative status and inflammatory state parameters in control (Group A) and supplemented with 50 
mg/kg/die of VigoorsanTM for 30 days (Group B) cows.
Group TNF-α IL-1β IL10 MCP1 d-Roms BAP OXY
 pg/ml png/ml pg/ml pg/ml U CARR μmoli/L mmoli/L
A 441.2 A 363.4 A 53.20 B 142.5 A 57.50 A 1854 B 298 B
B 376.4 B 287.6 B 96.11 A 79.11 B 47.22 B 2948 A 347 A
MSE 10.1 11.4 5.8 8.7 1.6 268 17.3
             A, B: P<0.01
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production merits further studies, in particular 
concerning the intracellular transduction pathways 
involved for the beneficial effects of VigoorsanTM.
Recent studies have demonstrated that 
Aloe arborescens has immunostimulating activity 
in animal trials (Infascelli et al., 2010) and it was 
also found to have beneficial phytotherapeutic 
and anti-tumoral properties (Lissoni et al., 2009). 
It is known that the anti-tumoral properties of 
Aloe depend not only on its immuno-modulatory 
effect, but also on a direct inhibition of cancer 
cell proliferation (Bedini et al., 2009). Di Luccia 
et al. (2013) analysed the composition of an Aloe 
arborescens leaf extract by gas chromatography-
mass spectrometry analysis and found it is rich in 
Aloe-emodin, a hydroxyl anthraquinone with known 
anti-tumoral activity and in several compounds 
with anti-oxidant properties. Accordingly, they 
showed that the Aloe extract has antiproliferative 
effects on several human transformed cell lines and 
exhibits pro-differentiative effects on both primary 
and immortalized human keratinocyte. Proteomic 
analysis of whole cell extracts revealed the 
presence of proteins with a strong anti-proliferative 
and antimicrobial activity specifically induced in 
human keratinocytes by Aloe treatment supporting 
its application as a therapeutic agent.
In conclusion, this study shows that 
the supplementation of Aloe arborescens and 
β-carotene in the diet of buffalo cows ameliorates 
the inflammatory state and oxidative stress. Also, 
results suggest an immunostimulating activity that 
may be of great importance for ruminants during 
transition. Further studies will be addressed to 
the identification of these components and the 
molecular mechanisms underlying their effects.
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